Assessing the appropriateness of antifungal prescribing: key results from the implementation of a novel audit tool in Australian hospitals
This study outlines the successful implementation of the Antifungal NAPS, a standardized electronic audit tool for the assessment of antifungal prescribing quality. Key areas for quality improvement identified were the overuse of empirical fluconazole for urinary tract and intra-abdominal infections, the importance of invasive fungal infection risk assessment to guide prophylaxis prescribing and greater infectious diseases and antifungal stewardship oversight of antifungal prescribing to guide optimal prescribing.
Authors
- Monica A. Slavin (ORCID: https://orcid.org/0000-0002-8443-314X)
- David C. M. Kong (ORCID: https://orcid.org/0000-0002-5022-9060)
- Rodney James (ORCID: https://orcid.org/0000-0003-1425-029X)
- Karin Thursky (ORCID: https://orcid.org/0000-0002-7400-232X)
- Anna Khanina (ORCID: https://orcid.org/0000-0003-2988-1676)
- Nikhil Singh (ORCID: https://orcid.org/0009-0009-5264-2447)
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Peter Doherty Institute (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1093/jac/dkaf044
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- National Health and Medical Research Council